Ocugen, Bharat Biotech COVID vaccine shows better safety/eff

Ocugen (OCGN) said interim data from phase 2/3 trial of Covaxin, developed by India's Bharat Biotech, was published in a journal and mentioned that the COVID-19 vaccine showed efficacy...

Related Keywords

Mexico , United States , Harare , Mashonaland East , Zimbabwe , India , American , Bharat , Tafadzwa Ufumeli Getty , Krishna Ella , , Covaxin Vaccine Administered In Harare , Getty Images , Bharat Biotech , Lancet Infectious Diseases , Bharat Biotech Chairman , Managing Director Krishna , North American ,